Zantac Lawyers in Columbus, OH | Clark, Perdue & List

During these unprecedented times, Clark, Perdue, & List Co, LPA is here to fully support your needs in a timely and safe manner. COVID-19 should not affect your ability to investigate a personal injury case. We currently remain open and are still accepting new cases. With your safety top of mind, we are scheduling all meetings via telephone or video conference at this time.

Zantac Lawyers in Columbus, OH

What is Zantac?

Zantac is a treatment for heartburn, acid reflux, and ulcers of the stomach and intestines. It has been voluntarily recalled because of the presence of NDMA (N-Nitrosodimethylamine) which is a probable carcinogen. We represent individuals who had negative consequences as a result of taking Zantac.

N-nitrosodimethylamine (NDMA) Exposure from Zantac

NDMA is an organic chemical that has been known to have dangerous effects for more than 40 years. The FDA, EPA, and World Health Organization all classify NDMA as a carcinogen. The Agency for Toxic Substances and Disease Registry, states in their toxicological profiles that NDMA has been shown to lead to cancer in animals and it is probable that it does the same in humans. Researchers believe that NDMA is produced by the reaction between the body’s enzymes and Zantac. 

Within a few years of being introduced, scientific studies began to suggest that NMDA resulted from the use of Zantac. Over the decades, many studies had similar findings. In March 2016, researchers from Stanford University published a study in Carcinogenesis in which patients’ NDMA levels increased 400x when taking Zantac. This research raised concerns about the drug and indicated a need to further study the dangers it may pose.  

On September 13, 2019 the FDA, announced that low levels of N-nitrosodimethylamine (NDMA) were found in Zantac.  Both the European Medicines Agency and Health Canada issued similar warnings on the same day. A voluntary recall of 14 lots of the prescription ranitidine was issued after the FDA’s warning in September. 

Animal studies associated NDMA with liver cancer, colorectal cancer, and more. Scientists believe that NDMA likely affects humans similarly. That could mean that NDMA from Zantac could be associated with the following cancers.

Cancers Associated with NDMA may include, but not limited to: 

  • Bladder Cancer
  • Stomach Cancer
  • Kidney Cancer
  • Prostate Cancer
  • Pancreatic Cancer
  • Small Intestine Cancer
  • Colorectal Cancer
  • Colon Cancer
  • Liver Cancer
  • Esophageal Cancer
  • Leukemia
  • Other Digestive Tract Cancers

Do you believe a cancer diagnosis is linked to Zantac?

Are You Eligible for a Claim?

If you or a loved one has developed cancer after were taking Zantac, you may be eligible for compensation. Contact our attorneys for a free consultation to discuss your potential case. 

Currently, there are lawsuits filed against the manufacturer of Zantac, alleging that it intentionally concealed risks and continued to distribute the medication despite the known risks.

Like millions of Americans, you may have taken this drug that was deemed to be safe and effective for a common ailment. Now you may be unfortunately stricken with a life-threatening disease that will physically, emotionally, and financially burden you and your loved ones. If you’ve lost a loved one to cancer after taking Zantac, you may be eligible for a claim as well. Let us help you and your family get justice. Call us today! You will receive:

  1. Free consultation over the phone
  2. Easy consultation, with no obligations
  3. Expert advice and case review from an experienced drug injury lawyer

If you or a loved one has been harmed by a dangerous drug, such as Zantac, contact us for a free consultation today. You may be entitled to financial compensation.

RECENT BLOG POSTS ABOUT DANGEROUS DRUGS

FDA Proposes Recall of Zantac

The Food and Drug Administration has requested drug manufacturers recall the popular heart burn medication, Zantac. This move comes as a continuing FDA investigation has found that Zantac, and other drugs with the active ingredient ranitidine, often contain...

read more

Zantac Linked to Cancer Risk When Stored in High Heat

In a previous post, we wrote about the FDA's investigation into the heartburn medication, Zantac, and other drugs containing ranitidine. The problem is that ranitidine has been found to contain N-Nitrosodimethylamine (“NDMA”), a suspected cancer causing agent in...

read more

Zantac Cancer Risk

Zantac, a popular heartburn medication, has been pulled from major retailers shelves because some of its ingredients may be linked to Zantac cancer risk.  The Food and Drug Administration ("FDA") continues to investigate the Zantac cancer risk, noting that "FDA is...

read more

Taxotere Hair Loss MDL Ordered

The Judicial Panel on Multidistrict Litigation ordered consolidation of all Taxotere hair loss cases on October 2, 2016. The panel noted that nearly 90 cases, alleging permanent hair loss resulting for the use of the chemotherapy drug, Taxotere, have been filed...

read more

Study Links Proton Pump Inhibitors to Stroke

Clark, Perdue & List is actively investigating cases involving patients suffering from kidney damage as a result of using popular heart burn medications, including Nexium, Prilosec, and Prevacid, have been linked to kidney damage. Studies have shown a link between...

read more

Heartburn Medication Causes Kidney Damage Study Finds

A recent study finds that commonly prescribed heartburn medication can cause kidney damage. Proton Pump Inhibitors ("PPI's), among the must widely prescribed medications in the United States, can cause kidney disease and kidney failure.  These drugs are used to treat...

read more